SEATTLE, April 14, 2021, (MEDGADGET) — A middle implant ear is a small device designed for people suffering from a mild-moderate mix or sensorineural hearing loss and conductive hearing loss. It is inserted into the middle ear for aiding in hearing. It is also recommended in earmould allergies, skin problems, ear infections, collapsed or closed ear canals, etc. conditions. The difference between middle ear implant and other hearing aid is that it does not require a speaker. Middle ear implant transmits sound to the middle ear through the microphone placed behind the ear. The microphone converts sound too mechanical vibration and are sent to a floating mass transducer placed in the middle ear.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/137
Middle ear implants are classified as piezoelectric and electromagnetic. Piezoelectric uses piezoelectric crystal, applied electric charge cause crystals to bend and the bend crystal creates an electric charge that causes inner ear bones to vibrate. Whereas, electromagnetic use external microphone and send the signal through the coil and converts to a magnetic field. Out of these two products, the piezoelectric middle ear implant is expected to contribute a major share to the overall middle ear implants industry. Based on the type of hearing loss, the market is segmented into conductive, sensorineural, and mixed.
Market Taxonomy
The global market is classified based on the following segments:
Product Type
- Piezoelectric Middle Ear Implant
- Electromagnetic Middle Ear Implant
Type of Hearing Loss
- Conductive
- Sensorineural
- Mixed (conductive and sensorineural)
End Users
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinic
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/137
Rising government support in developed regions to address growing prevalence of hearing loss is expected to augment growth of middle ear implants market
Increasing concerns over hearing loss are expected to drive the growth of the market in middle ear implants. As per a WHO report, as of 2012, around 360 million people worldwide suffered from hearing loss, which accounts for around 5.3% of the world population. Out of the total hearing loss patient population, 91% were adults with children accounting for the rest. The increasing cases of hearing loss due to exposure to loud noise, trauma, viral infections, increasing geriatric population, and rising incidence of malformation of the inner ear are projected to drive the growth of the overall middle ear implants industry. Moreover, increasing government regulations for early screening, diagnosis, and treatment of hearing problems is further expected to augment the growth of the middle ear implant market. In the U.S., Medicaid regulates one such program called the Early and Periodic Screening, Diagnosis and Treatment (EPSDT) Program. EPSDT is mandated for children from birth to till age 21, which provides beneficiaries for early screening, diagnosis, and treatment of hearing aid. In Canada, hearing loss is covered under ICD-9 389.1 (Sensorineural Hearing Loss), 389.0 (Conductive Hearing Loss)—an initiative by various governmental and non-governmental organizations to spread awareness about early treatment of hearing loss. This creates a highly conducive environment for the growth of the global middle ear implants market. On February 6, 2016, Public Affairs & Campaigns of the U.K. initiated a campaign to protect audiology services. On February 25, 2015, WHO started the “Make Listening Safe Initiative” to mark March 3, 2015, as Ear care day to draw focus towards the danger of unsafe listening, early treatment, and promote safe practices. On the flip side, the availability of alternative treatments such as Bone-anchored devices and Cochlear implants is expected to limit the growth of the market.
North America and Europe are expected to hold a maximum share of the overall market, and this can be attributed to the growing disposable income and easy availability of middle ear implant devices in these regions. At the same time, Asia Pacific is projected to provide highly lucrative opportunities for the market growth owing to the increasing geriatric population and the rising number of cases of hearing loss reported each year.
Major middle ear implant products in the market:
Esteem Hearing Implant (Envoy Medical), MAXUM Hearing Implant (Ototronix), cochlear implant (CI) system (MED-EL Corporation), and Ossicular (middle ear) implant (Medtronic)
Major Players
Major players involved in the middle ear implants market include Envoy Medical, Ototronix, MED-EL Corporation, Medtronic, CENTILLION, and Cochlear.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/middle-ear-implants-market-137
Key Developments
- Key players in the market are involved in different business strategies such as gaining product approval from regulatory authorities, to expand their product portfolio. For instance, in August 2018, Envoy Medical Corporation, a U.S.-based company, received U.S. Food and Drug Administration (USFDA) for Esteem Hearing Implant. It is the first and only active middle ear implant to receive magnetic resonance (MR)-labeling for both 1.5 and 3.0 T scanning.
- Major companies in the market are focused on different business strategies such as gaining product approval from regulatory authorities, to expand their product portfolio. For instance, in July 2019, MED-EL Corporation, a U.S.-based company, received the U.S. Food and Drug Administration for the company’s cochlear implant system for single-sided deafness.
- Major companies in the market are involved in various business strategies such as research and development of novel products, in order to provide effective solutions for middle ear implants and gain a competitive edge in the market. For instance, in October 2018, Cochlear Limited announced the next phase in its long-term R&D program to develop implantable devices.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837